These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14970941)

  • 1. Apoptosis in cancer--implications for therapy.
    Schulze-Bergkamen H; Krammer PH
    Semin Oncol; 2004 Feb; 31(1):90-119. PubMed ID: 14970941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment.
    Rodriguez-Nieto S; Zhivotovsky B
    Curr Pharm Des; 2006; 12(34):4411-25. PubMed ID: 17168751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and medicinal chemistry approaches towards various apoptosis inducers.
    Vyas VK; Chintha C; Pandya MR
    Anticancer Agents Med Chem; 2013 Mar; 13(3):433-55. PubMed ID: 22721391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies.
    Zivny J; Klener P; Pytlik R; Andera L
    Curr Pharm Des; 2010 Jan; 16(1):11-33. PubMed ID: 20214615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis: a link between cancer genetics and chemotherapy.
    Johnstone RW; Ruefli AA; Lowe SW
    Cell; 2002 Jan; 108(2):153-64. PubMed ID: 11832206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of nitric oxide in cancer.
    Bonavida B; Khineche S; Huerta-Yepez S; Garbán H
    Drug Resist Updat; 2006 Jun; 9(3):157-73. PubMed ID: 16822706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting survivin in cancer: patent review.
    Kanwar JR; Kamalapuram SK; Kanwar RK
    Expert Opin Ther Pat; 2010 Dec; 20(12):1723-37. PubMed ID: 21083520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the apoptotic and survival signaling in cancer cells and their potential therapeutic implications.
    Kabore AF; Johnston JB; Gibson SB
    Curr Cancer Drug Targets; 2004 Mar; 4(2):147-63. PubMed ID: 15032666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
    Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARTS-based anticancer therapy: taking aim at cancer stem cells.
    Elhasid R; Larisch S
    Future Oncol; 2011 Oct; 7(10):1185-94. PubMed ID: 21992730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of HMGA proteins in cancer cell chemoresistance.
    D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
    J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion-mediated apoptosis resistance in cancer.
    Westhoff MA; Fulda S
    Drug Resist Updat; 2009; 12(4-5):127-36. PubMed ID: 19726220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted manipulation of apoptosis in cancer treatment.
    Call JA; Eckhardt SG; Camidge DR
    Lancet Oncol; 2008 Oct; 9(10):1002-11. PubMed ID: 18760670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting TRAIL towards the clinic.
    Mahalingam D; Oldenhuis CN; Szegezdi E; Giles FJ; de Vries EG; de Jong S; Nawrocki ST
    Curr Drug Targets; 2011 Dec; 12(14):2079-90. PubMed ID: 21777191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Updated Review on Implications of Autophagy and Apoptosis in Tumorigenesis: Possible Alterations in Autophagy through Engineered Nanomaterials and Their Importance in Cancer Therapy.
    Ghaznavi H; Shirvaliloo M; Zarebkohan A; Shams Z; Radnia F; Bahmanpour Z; Sargazi S; Saravani R; Shirvalilou S; Shahraki O; Shahraki S; Nazarlou Z; Sheervalilou R
    Mol Pharmacol; 2021 Aug; 100(2):119-143. PubMed ID: 33990406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
    Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
    J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of signal transduction in cancer treatment and drug resistance.
    Liem AA; Chamberlain MP; Wolf CR; Thompson AM
    Eur J Surg Oncol; 2002 Sep; 28(6):679-84. PubMed ID: 12359208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.